These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28977694)

  • 1. Denosumab-related osteonecrosis of the jaw: A retrospective study.
    Egloff-Juras C; Gallois A; Salleron J; Massard V; Dolivet G; Guillet J; Phulpin B
    J Oral Pathol Med; 2018 Jan; 47(1):66-70. PubMed ID: 28977694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Denosumab-related osteonecrosis of the jaw after tooth extraction and the effects of a short drug holiday in cancer patients: a multicenter retrospective study.
    Hasegawa T; Ueda N; Yamada SI; Kato S; Iwata E; Hayashida S; Kojima Y; Shinohara M; Tojo I; Nakahara H; Yamaguchi T; Kirita T; Kurita H; Shibuya Y; Soutome S; Akashi M;
    Osteoporos Int; 2021 Nov; 32(11):2323-2333. PubMed ID: 33997909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteonecrosis of the jaw in patients treated with denosumab: A multicenter case series.
    Aljohani S; Gaudin R; Weiser J; Tröltzsch M; Ehrenfeld M; Kaeppler G; Smeets R; Otto S
    J Craniomaxillofac Surg; 2018 Sep; 46(9):1515-1525. PubMed ID: 29983309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
    Soutome S; Hayashida S; Funahara M; Sakamoto Y; Kojima Y; Yanamoto S; Umeda M
    PLoS One; 2018; 13(7):e0201343. PubMed ID: 30048523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical course and therapeutic outcomes of operatively and non-operatively managed patients with denosumab-related osteonecrosis of the jaw (DRONJ).
    Hoefert S; Yuan A; Munz A; Grimm M; Elayouti A; Reinert S
    J Craniomaxillofac Surg; 2017 Apr; 45(4):570-578. PubMed ID: 28238559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and Risk Factors of Osteonecrosis of the Jaw in Advanced Cancer Patients after Treatment with Zoledronic Acid or Denosumab: A Retrospective Cohort Study.
    Kajizono M; Sada H; Sugiura Y; Soga Y; Kitamura Y; Matsuoka J; Sendo T
    Biol Pharm Bull; 2015; 38(12):1850-5. PubMed ID: 26632176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates.
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Koerdt S; Otto S; Pautke C
    Br J Oral Maxillofac Surg; 2014 Apr; 52(4):308-13. PubMed ID: 24582013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Denosumab, an Alternative to Bisphosphonates but also Associated with Osteonecrosis of the Jaw--What is the Risk?
    Sidhu HK
    Dent Update; 2015 Jun; 42(5):436-8, 440. PubMed ID: 26964445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
    Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ
    Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients: an update.
    Utreja A; Almas K; Javed F
    Odontostomatol Trop; 2013 Jun; 36(142):38-46. PubMed ID: 24073539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a surgical treatment of denosumab-related osteonecrosis of the jaws.
    Pichardo SE; van Merkesteyn JP
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Sep; 122(3):272-8. PubMed ID: 27234854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraindividual comparison of preoperative (99m)Tc-MDP SPECT/CT and intraoperative and histopathological findings in patients with bisphosphonate- or denosumab-related osteonecrosis of the jaw.
    Assaf AT; Zrnc TA; Remus CC; Adam G; Zustin J; Heiland M; Friedrich RE; Derlin T
    J Craniomaxillofac Surg; 2015 Oct; 43(8):1461-9. PubMed ID: 26232916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution of a case of denosumab-related osteonecrosis of the jaw after tooth extraction.
    Bujaldón-Rodríguez R; Gómez-Moreno G; Leizaola-Cardesa IO; Aguilar-Salvatierra A
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2314-2317. PubMed ID: 30964153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of new targeted cancer therapies in children: effects on dental development and risk of jaw osteonecrosis: a review.
    Hernandez M; Phulpin B; Mansuy L; Droz D
    J Oral Pathol Med; 2017 May; 46(5):321-326. PubMed ID: 27778394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use and safety of denosumab in cancer patients.
    Manzaneque A; Chaguaceda C; Mensa M; Bastida C; Creus-Baró N
    Int J Clin Pharm; 2017 Jun; 39(3):522-526. PubMed ID: 28382583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Denosumab-related osteonecrosis of the jaws: successful management with a conservative surgical approach.
    de Souza Póvoa RC; Marlierè DA; da Silveira HM; Pires FR
    Spec Care Dentist; 2016 Jul; 36(4):231-6. PubMed ID: 26859582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Denosumab: a case of MRONJ with resolution.
    Lyttle CV; Patterson H
    Br Dent J; 2016 Jun; 220(12):623-5. PubMed ID: 27338901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasonic Piezoelectric Bone Surgery Combined With Leukocyte and Platelet-Rich Fibrin and Pedicled Buccal Fat Pad Flap in Denosumab-Related Osteonecrosis of the Jaw.
    Şahin O; Odabaşi O; Ekmekcioğlu C
    J Craniofac Surg; 2019 Jul; 30(5):e434-e436. PubMed ID: 31299805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures.
    Pittman K; Antill YC; Goldrick A; Goh J; de Boer RH
    Asia Pac J Clin Oncol; 2017 Aug; 13(4):266-276. PubMed ID: 27862983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic polarization shifting from M1 to M2 macrophages in reduced osteonecrosis of the jaw-like lesions by cessation of anti-RANKL antibody in mice.
    Tamaki S; Kuroshima S; Hayano H; Nakajima K; Kakehashi H; Ishisaki A; Sawase T
    Bone; 2020 Dec; 141():115560. PubMed ID: 32730924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.